We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use °Ç¸ç³Ô¹Ï, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Statement setting out advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of chikungunya vaccines in UK travellers.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the groups that should be prioritised for vaccination.
Updated advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 booster vaccine programme for winter 2021 to 2022.
Statement setting out the recommendation from the Joint Committee on Vaccination and Immunisation (JCVI) on meningococcal capsular group B (MenB) adolescent vaccination.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the benefits of a third primary COVID-19 vaccine dose in individuals aged 12 years and over with severe immunosuppression.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve °Ç¸ç³Ô¹Ï, we’d like to know more about your visit today. .